A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
BioNTech SE
BioNTech SE
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Cedars-Sinai Medical Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
DualityBio Inc.
Big Ten Cancer Research Consortium
University of Nebraska
Genfit
RenJi Hospital
Minia University
University of Colorado, Denver
Oslo University Hospital
University Hospital, Ghent
First Affiliated Hospital of Zhejiang University
Peking University Third Hospital
Region Skane
University of Leipzig